MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells

MicroRNA-200b Regulates Vascular Endothelial Growth Factor-Mediated Alterations in Diabetic Retinopathy

(2011) K. McArthur et al.   DIABETES

Versatility of MicroRNA Biogenesis

(2011) Naama Volk et al.   PLoS One

MicroRNA145 Targets BNIP3 and Suppresses Prostate Cancer Progression

(2010) Xueqin Chen et al.   CANCER RESEARCH

Regulation of microRNA-145 by growth arrest and differentiation

(2010) Gaspare La Rocca et al.   EXPERIMENTAL CELL RESEARCH

EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells

(2010) N. Riggi et al.   GENES & DEVELOPMENT

Expanding the MicroRNA Targeting Code: Functional Sites with Centered Pairing

(2010) Chanseok Shin et al.   MOLECULAR CELL

The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art

(2009) Irina Arnaoutova et al.   ANGIOGENESIS

MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1

(2009) M. Sachdeva et al.   CANCER RESEARCH

MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation

(2009) Yunhui Cheng et al.   CIRCULATION RESEARCH

MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo

(2009) Bo Liu et al.   LUNG CANCER

The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors

(2009) L. Jain et al.   MOLECULAR CANCER THERAPEUTICS

Decreased Expression of MicroRNA-143 and -145 in Human Gastric Cancers

(2009) Takeshi Takagi et al.   ONCOLOGY

p53 represses c-Myc through induction of the tumor suppressor miR-145

(2009) M. Sachdeva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice

(2008) E S Rennel et al.   BRITISH JOURNAL OF CANCER